The White House has announced plans to invest $1 billion into making rapid at-home tests for the Chinese Communist Party (CCP) Virus, which causes the disease COVID-19, widely available. This comes days after the Food and Drug Administration (FDA) granted emergency use authorization for the ACON Laboratories Flowflex COVID-19 Home Test—a new rapid antigen test that can…